(Q40474924)

English

Multiagent vaccines vectored by Venezuelan equine encephalitis virus replicon elicits immune responses to Marburg virus and protection against anthrax and botulinum neurotoxin in mice.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16828936%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Multiagent vaccines vectored by Venezuelan equine encephalitis virus replicon elicits immune responses to Marburg virus and protection against anthrax and botulinum neurotoxin in mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16828936%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

vector-borne disease

0 references

Marburgvirus (genus)

0 references

equine encephalitis

1 reference

based on heuristic

inferred from title

Venezuelan equine encephalitis

1 reference

based on heuristic

inferred from title

Venezuelan equine encephalitis virus

object named as

Venezuelan equine encephalitis virus

1 reference

based on heuristic

inferred from title

Jennifer L. Groebner

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16828936%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Susan L. Welkos

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16828936%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Alan Schmaljohn

5

object named as

Alan L Schmaljohn

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16828936%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

4

object named as

Diane L Negley

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16828936%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

John S Lee

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16828936%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Angela G Hadjipanayis

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16828936%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Leonard A Smith

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16828936%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Jonathan F Smith

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16828936%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

language of work or name

0 references

publication date

21 June 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16828936%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16828936%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16828936%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

47-48

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16828936%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

6886-6892

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16828936%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.004

7 January 2021

Anthrax as a biological weapon, 2002: updated recommendations for management

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.004

7 January 2021

A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.004

7 January 2021

Immune correlates of protection against anthrax

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.004

7 January 2021

Experimental anthrax vaccines: efficacy of adjuvants combined with protective antigen against an aerosol Bacillus anthracis spore challenge in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.004

7 January 2021

In vitro correlate of immunity in a rabbit model of inhalational anthrax

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.004

7 January 2021

Anthrax post-vaccinal cell-mediated immunity in humans: kinetics pattern

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.004

7 January 2021

Development of an in vitro-based potency assay for anthrax vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.004

7 January 2021

In-vitro characterisation of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.004

7 January 2021

The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.004

7 January 2021

Venezuelan equine encephalitis virus-vectored vaccines protect mice against anthrax spore challenge.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.004

7 January 2021

Development of recombinant vaccines for botulinum neurotoxin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.004

7 January 2021

Fermentation, Purification, and Efficacy of a Recombinant Vaccine Candidate against Botulinum Neurotoxin Type F from Pichia pastoris

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.004

7 January 2021

The immunogenicity in humans of a botulinum type F vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.004

7 January 2021

Candidate vaccine against botulinum neurotoxin serotype A derived from a Venezuelan equine encephalitis virus vector system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.004

7 January 2021

Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.004

7 January 2021

Marburg virus vaccines: comparing classical and new approaches

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.004

7 January 2021

Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.004

7 January 2021

Immune protection against staphylococcal enterotoxin-induced toxic shock by vaccination with a Venezuelan equine encephalitis virus replicon

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.004

7 January 2021

Antigenicity and vaccine potential of Marburg virus glycoprotein expressed by baculovirus recombinants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.004

7 January 2021

Purification, potency, and efficacy of the botulinum neurotoxin type A binding domain from Pichia pastoris as a recombinant vaccine candidate.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.004

7 January 2021

Protection against anthrax with recombinant virus-expressed protective antigen in experimental animals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.004

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40474924&oldid=1948620537"